Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
covid-19
covid-19 vaccination
facial diplegia
guillain-barré syndrome (gbs)
neuromuscular
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
16
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Serious neurologic complications from coronavirus disease 2019 (COVID-19) vaccination are rare, and only a few cases of Guillain-Barré syndrome (GBS) have been reported after COVID-19 vaccination. We present the first reported case of the facial diplegia variant of GBS after recent COVID-19 vaccination in a pregnant woman. The 30-year-old patient was 27 weeks pregnant at the time she was diagnosed with the facial diplegia variant of GBS. Her symptoms began two weeks after she received the Ad26.COV2.S COVID-19 vaccine. A thorough evaluation for GBS was done, including a lumbar puncture that demonstrated elevated cerebrospinal fluid (CSF) protein and nerve conduction study (NCS) that found evidence of a diffuse sensorimotor demyelinating polyneuropathy. Nasal swab testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was negative on two occasions five days apart. All other diagnostic testing was unremarkable or nonexplanatory of the patient's clinical presentation. She was started on intravenous immunoglobulin (IVIG) and had significantly improved dysphasia, dysarthria, and facial strength. The patient recovered to baseline four weeks after presentation.
Identifiants
pubmed: 35371813
doi: 10.7759/cureus.22341
pmc: PMC8938242
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e22341Informations de copyright
Copyright © 2022, Zubair et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann Neurol. 2021 Aug;90(2):315-318
pubmed: 34114269
Neurology. 2021 Apr 6;:
pubmed: 33824169
Neuroepidemiology. 2009;32(2):150-63
pubmed: 19088488
IDCases. 2021 Jul 12;25:e01226
pubmed: 34290962
Lancet. 2021 Mar 27;397(10280):1214-1228
pubmed: 33647239
Ideggyogy Sz. 2021 Jul 30;74(7-08):286-288
pubmed: 34370408
Ann Med Surg (Lond). 2021 Jul;67:102540
pubmed: 34249353
Am J Obstet Gynecol. 2021 May;224(5):484-495
pubmed: 33529575
BMJ Case Rep. 2021 Jul 30;14(7):
pubmed: 34330729
Open Forum Infect Dis. 2019 Mar 15;6(3):ofz071
pubmed: 31312665
Clin Case Rep. 2021 Aug 30;9(9):e04756
pubmed: 34484780
BMJ Case Rep. 2021 Apr 22;14(4):
pubmed: 33888484
Case Rep Infect Dis. 2021 May 8;2021:3619131
pubmed: 34055430
Hum Vaccin Immunother. 2021 Nov 2;17(11):4093-4096
pubmed: 34347563
Cureus. 2021 Feb 18;13(2):e13426
pubmed: 33758714
J Clin Neurosci. 2020 Jul;77:230-232
pubmed: 32410788